77 related articles for article (PubMed ID: 21840329)
1. Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profile in plasma of obese women.
Gómez-Santos C; Larqué E; Granero E; Hernández-Morante JJ; Garaulet M
Steroids; 2011 Dec; 76(13):1425-32. PubMed ID: 21840329
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women.
Gómez-Santos C; Hernández-Morante JJ; Tébar FJ; Granero E; Garaulet M
Clin Endocrinol (Oxf); 2012 Oct; 77(4):548-54. PubMed ID: 22136516
[TBL] [Abstract][Full Text] [Related]
3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone modifies rat fatty acid composition of serum and different adipose tissue depots and lowers serum insulin levels.
de Heredia FP; Larqué E; Zamora S; Garaulet M
J Endocrinol; 2009 Apr; 201(1):67-74. PubMed ID: 19144736
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
Diamond P; Cusan L; Gomez JL; Bélanger A; Labrie F
J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone-sulfate modifies human fatty acid composition of different adipose tissue depots.
Hernandez-Morante JJ; Cerezo D; Cruz RM; Larque E; Zamora S; Garaulet M
Obes Surg; 2011 Jan; 21(1):102-11. PubMed ID: 20094820
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels.
Al-Harithy RN
Saudi Med J; 2003 Aug; 24(8):837-41. PubMed ID: 12939667
[TBL] [Abstract][Full Text] [Related]
8. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the influence of sex hormones on homocysteine concentration in pre- and postmenopausal women].
Bednarek-Tupikowska G; Tupikowski K; Bohdanowicz-Pawlak A; Bidzińska B; Szymczak J; Filus A; Kuliczkowska J; Milewicz A
Pol Merkur Lekarski; 2005 Feb; 18(104):189-91. PubMed ID: 17877128
[TBL] [Abstract][Full Text] [Related]
10. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
[TBL] [Abstract][Full Text] [Related]
11. Dhea supplementation and cognition in postmenopausal women.
Parsons TD; Kratz KM; Thompson E; Stanczyk FZ; Buckwalter JG
Int J Neurosci; 2006 Feb; 116(2):141-55. PubMed ID: 16393880
[TBL] [Abstract][Full Text] [Related]
12. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects.
Monteleone P; Luisi M; De Filippis G; Colurcio B; Monteleone P; Genazzani AR; Maj M
Int J Eat Disord; 2003 Dec; 34(4):432-40. PubMed ID: 14566930
[TBL] [Abstract][Full Text] [Related]
14. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial.
Witt PM; Christensen JH; Ewertz M; Aardestrup IV; Schmidt EB
Br J Nutr; 2010 Aug; 104(3):318-25. PubMed ID: 20334707
[TBL] [Abstract][Full Text] [Related]
15. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
[TBL] [Abstract][Full Text] [Related]
16. The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women.
Kalleinen N; Polo O; Himanen SL; Joutsen A; Polo-Kantola P
Climacteric; 2008 Jun; 11(3):233-43. PubMed ID: 18568788
[TBL] [Abstract][Full Text] [Related]
17. Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women.
Bell RJ; Donath S; Davison SL; Davis SR
Menopause; 2006; 13(1):65-71. PubMed ID: 16607100
[TBL] [Abstract][Full Text] [Related]
18. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
19. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
20. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
Kok P; Kok SW; Buijs MM; Westenberg JJ; Roelfsema F; Frölich M; Stokkel MP; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
